Gilead Sciences GILD
NASDAQ GILD
$166.89 -0.68 (-0.41%)
At close: Nov 6, 2026 · 4:00 PM EST

Gilead Sciences (GILD) Return on Invested Capital [ROIC] (2009 - 2026)

Updated

Gilead Sciences' Return on Invested Capital [ROIC] came in at -5.97% for Q2 2026, down 21.90 percentage points from 15.93% a year earlier and down 25.08 percentage points from the prior quarter.

Analysis

Gilead Sciences (GILD) Return on Invested Capital [ROIC] (2009 - 2026) Analysis & Trends

For FY2025, Gilead Sciences' Return on Invested Capital [ROIC] was 18.60%, up 16.14 percentage points from FY2024.

  • Return on Invested Capital [ROIC] carries a five-year change of +18.16 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Invested Capital [ROIC] was 2.46% in FY2024 (-10.75 pp), 13.21% in FY2023 (+0.99 pp), 12.22% in FY2022 (-3.04 pp) and 15.26% in FY2021 (+14.81 pp).
  • The Q2 2026 figure represents the lowest quarterly Return on Invested Capital [ROIC] in data going back to Q3 2009.
  • Year-over-year, Return on Invested Capital [ROIC] increased in five of the last eight quarters, with an average year-over-year change of +2.21 percentage points.
  • The fastest year-over-year change in Return on Invested Capital [ROIC] over five years came in Q3 2025 (a gain of 17.64 percentage points), and the weakest in Q2 2026 (a drop of 21.90 percentage points).
  • Business Quant data shows GILD's Return on Invested Capital [ROIC] at 19.11% (Q1 2026), 18.50% (Q4 2025) and 18.91% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn 38.16%
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn 17.57%
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn 24.28%
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn 2.88%
5 Novartis Ag 315.51 Bn 288.75 Bn - -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn 24.11%
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn 15.60%
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn -6.11%
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn 12.34%
10 Vertex Pharmaceuticals 138.73 Bn 110.72 Bn 2.91 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -6.11%
Jun 30, 2026 -5.97%
Mar 31, 2026 19.11%
Dec 31, 2025 18.50%
Sep 30, 2025 18.91%
Jun 30, 2025 15.93%
Mar 31, 2025 15.97%
Dec 31, 2024 2.63%
Sep 30, 2024 1.27%
Jun 30, 2024 4.08%
Mar 31, 2024 1.48%
Dec 31, 2023 13.10%
Sep 30, 2023 14.22%
Jun 30, 2023 13.56%
Mar 31, 2023 14.55%
Dec 31, 2022 12.42%
Sep 30, 2022 9.43%
Jun 30, 2022 11.22%
Mar 31, 2022 11.79%
Dec 31, 2021 15.33%
API Access

Gilead Sciences Return on Invested Capital [ROIC] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=GILD&period=max&api_key=YOUR_API_KEY